CD274 and neoplasm: To address challenges of CAR T cell effectiveness in solid tumors, we have engineered PD-L1-targeting MC9999 CAR T cells and have shown cytotoxicity and antitumor effects against various PD-L1-expressing tumor cells and macrophages that modulate the TME.